OPHTAI WAS INVOLVED IN A LARGE TELERETINAL SCREENING PROGRAM ORGANIZED BY UNIVERSITY OF WASHINGTON TO ASSESS DIABETIC RETINOPATHY ON 23,724 PATIENTS AT HOSPITALS IN SEATTLE AND ATLANTA On January 7, 2021, Aaron Lee’s article in the ADA Diabetes Care was...
Recent Comments